Release Date: 25/02/09 18:36 Summary: 2009 Interim Results Presentation Price Sensitive: No Download Document 644.01KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%